Clinical Trials Directory

Trials / Completed

CompletedNCT01121172

Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)

Serum Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)in Obese Children and Adolescents.

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
2 Years – 16 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents. So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2012-06-01
Completion
2014-01-01
First posted
2010-05-12
Last updated
2016-05-19
Results posted
2016-05-19

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01121172. Inclusion in this directory is not an endorsement.